Skip to textbook content
Doctor’s PassportTextbook
TopicsAll topics

Loading topic navigation…

Textbook navigation
TopicsAll topics

Loading topic navigation…

Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.

Intermediate care and hospital at home

Medicine of older adults · UK scope · Sources checked 27 Aug 2026 · Clinical review pending

RapidFull
!
Deterioration during home-based acute care

Home location must not delay emergency response to sepsis, respiratory failure, acute coronary syndrome, stroke, haemorrhage or treatment complication. Remote monitoring can fail or lag behind symptoms.

Action: Use the service escalation protocol, obtain ABCDE observations and glucose where indicated and contact the named senior clinician immediately. Call 999 and transfer when the condition exceeds the agreed home ceiling or response capability, sending diagnosis, medicines, results, advance recommendations and recent trends with the person.

Synopsis

Select and deliver time-limited home or bed-based alternatives safely through comprehensive assessment, clear clinical ownership, rehabilitation goals, monitoring and escalation while distinguishing intermediate care, reablement and hospital-level treatment at home.

  • Intermediate care provides time-limited rehabilitation, recovery and assessment; hospital at home provides hospital-level acute treatment in the person's residence. Their staffing, risk and governance are not interchangeable.
  • First-line selection confirms diagnosis and acuity, physiological stability, delirium risk, function, home access, communication, treatment needs, monitoring and caregiver willingness.
  • Use comprehensive geriatric assessment and person-centred goals; do not exclude solely because of age, frailty, dementia, care-home residence or uncertain recovery.
  • Hospital at home requires a named senior clinician, agreed visit and monitoring frequency, prescribing and test routes and rapid escalation or transfer capacity.
  • Intermediate care should practise activities that matter in the actual environment and review progress, rather than becoming a waiting place for long-term care.
  • Remote observations can supplement assessment but do not replace hands-on review when cognition, equipment reliability or clinical change makes data uncertain.
  • Ask carers privately about access, overnight responsibility and technical tasks; a home-based service must not shift professional workload to unwilling family.
  • New hypoxia, hypotension, sepsis physiology, focal neurology, uncontrolled pain or inability to meet basic needs exceeds many home pathways and triggers urgent review.
  • Plan end points at entry: recovery goal, expected duration, review date, discharge destination and what non-response will prompt diagnosis reassessment or different care.
  • At end of life, home hospital treatment may still be appropriate when it relieves a reversible problem without disproportionate burden, but goals and transfer ceiling must be explicit.

Key red flags

New oxygen requirement, severe desaturation, respiratory exhaustion or hypercapnic drowsiness requires urgent escalation.

Hypotension, rising respiratory rate, oliguria, mottling or acute confusion can indicate sepsis or shock.

Chest pain, syncope, new arrhythmia or focal neurological deficit is not suitable for routine remote review.

A carer becoming unavailable when the person cannot meet basic needs makes the home pathway immediately unsafe.

Failed oxygen, infusion, monitoring or communication equipment requires the predefined technical and clinical contingency.

Repeated missed visits or alerts with no accountable response is a governance emergency.

Safeguarding, coercion or unsafe controlled-drug access may require an alternative setting even if physiology is stable.

Home-pathway instability

Worsening hypoxia, hypotension, delirium, chest pain, focal neurology, sepsis or uncontrolled symptoms requires urgent senior assessment and possible transfer.

Investigation priorities

01
First-line pathway suitability assessmentFirst stepFirst line

Define acute diagnosis, physiological trend, treatment, function, cognition, home, support and likely deterioration before enrolment.

Management branches

Selection pathwayMatch need to service capability

Hospital avoidance, early supported discharge or rehabilitation outside acute hospital is being considered.

  1. Complete clinical, functional, cognitive, home, carer and capacity assessment and define whether need is acute hospital-level or rehabilitative.
  2. Explain alternatives and monitoring, obtain informed agreement or lawful decision and confirm the local service can meet diagnostics, visits and response times.
  3. Set the treatment or functional goal, named clinical owner, review date, escalation threshold and expected exit before transfer.
Open full textbook →Answer 2 questions
Sources and review status5 sources · checked 27 Aug 2026 · clinical review pending+
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Apply principles in context and verify current guidance when a decision affects care. Source check completed 27 Aug 2026; clinical approval remains outstanding.

  • NICE NG74 intermediate care recommendationsAccess, assessment, person-centred goals, home and bed-based services, review and transition.
  • NHS England virtual wardsHospital-at-home model, clinical oversight, monitoring, acute treatment and system implementation.
  • NICE NG253 suspected sepsis in adultsHigh-risk deterioration, observation, treatment and escalation requirements.
  • Hospital discharge and community support guidancePathway selection, community support, discharge-to-assess and accountability in England.
  • British Geriatrics Society virtual wards positionOlder-person selection, comprehensive geriatric assessment, equality and hospital-at-home safeguards.

Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem · Content changes

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom